跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法打開新的分頁/視窗

Elsevier
與我們共同出版

Amadea Britton

AB

Amadea Britton

CDC/NCIRD, USA

Preliminary Talk Title: U.S. Experience with Respiratory Syncytial Virus (RSV) Prevention Product Introduction

Dr. Amadea Britton currently serves as a Medical Officer at the U.S. Centers for Disease Control and Prevention (CDC) where she works on the Vaccine Effectiveness and Policy Team in the Coronavirus and Other Respiratory Viruses Division. She is the Co-Lead of the U.S. Advisory Committee on Immunization Practices (ACIP) Work Group for RSV Vaccines in Adults and has contributed extensively to U.S. RSV vaccine policy development. Dr. Britton is a board-certified physician and completed Internal Medicine/Pediatrics clinical training at Duke University. She also holds a Master of Science from the Harvard T.H. Chan School of Public Health and is a former CDC Epidemic Intelligence Service Officer.